Skip to main content
logo
Glenmark Pharmaceuticals Limited (BOM:532296)
India flag India · Delayed Price · Currency is INR
2,181.55
+276.40 (14.51%)
At close: Jul 11, 2025

Glenmark Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Glenmark Pharmaceuticals had annual revenue of 134.35B INR with 6.25% growth. Glenmark Pharmaceuticals had revenue of 32.68B in the quarter ending March 31, 2025, a decrease of -16.11%.

Revenue
134.35B
Revenue Growth
+6.25%
P/S Ratio
4.58
Revenue / Employee
8.96M
Employees
14,989
Market Cap
615.51B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Mar 31, 2025 134.35B 7.90B 6.25%
Mar 31, 2024 126.45B 9.90B 8.49%
Mar 31, 2023 116.56B -6.49B -5.28%
Mar 31, 2022 123.05B 13.61B 12.44%
Mar 31, 2021 109.44B 2.87B 2.69%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reliance Industries 9,646.93B
HDFC Bank 2,728.47B
Tata Consultancy Services 2,568.46B
Bharti Airtel 1,729.85B
ICICI Bank 2,006.54B
State Bank of India 3,429.39B
Infosys 1,647.16B
Bajaj Finance 370.20B
Revenue Rankings

Glenmark Pharmaceuticals News

More News